136 related articles for article (PubMed ID: 8219040)
21. Contribution of NR2A and NR2B NMDA subunits to bidirectional synaptic plasticity in the hippocampus in vivo.
Fox CJ; Russell KI; Wang YT; Christie BR
Hippocampus; 2006; 16(11):907-15. PubMed ID: 17024679
[TBL] [Abstract][Full Text] [Related]
22. Reparatory effects of nicotine on NMDA receptor-mediated synaptic plasticity in the hippocampal CA1 region of chronically lead-exposed rats.
Wang HL; Chen XT; Luo L; Lou ZY; Wang S; Chen JT; Wang M; Sun LG; Ruan DY
Eur J Neurosci; 2006 Mar; 23(5):1111-9. PubMed ID: 16553775
[TBL] [Abstract][Full Text] [Related]
23. Pregnenolone sulfate enhances long-term potentiation in CA1 in rat hippocampus slices through the modulation of N-methyl-D-aspartate receptors.
Sliwinski A; Monnet FP; Schumacher M; Morin-Surun MP
J Neurosci Res; 2004 Dec; 78(5):691-701. PubMed ID: 15505794
[TBL] [Abstract][Full Text] [Related]
24. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
Priestley T; Marshall GR; Hill RG; Kemp JA
Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
[TBL] [Abstract][Full Text] [Related]
25. Bidirectional modification of CA1 synapses in the adult hippocampus in vivo.
Heynen AJ; Abraham WC; Bear MF
Nature; 1996 May; 381(6578):163-6. PubMed ID: 8610015
[TBL] [Abstract][Full Text] [Related]
26. Naloxone blocks long-term depression of excitatory transmission in rat CA1 hippocampus in vitro.
Francesconi W; Berton F; Demuro A; Madamba SG; Siggins GR
Arch Ital Biol; 1997 Jan; 135(1):37-48. PubMed ID: 9139581
[TBL] [Abstract][Full Text] [Related]
27. Transient and sustained types of long-term potentiation in the CA1 area of the rat hippocampus.
Volianskis A; Jensen MS
J Physiol; 2003 Jul; 550(Pt 2):459-92. PubMed ID: 12794181
[TBL] [Abstract][Full Text] [Related]
28. Evidence for nitric oxide synthase inhibitor-sensitive and insensitive hippocampal synaptic potentiation.
Gribkoff VK; Lum-Ragan JT
J Neurophysiol; 1992 Aug; 68(2):639-42. PubMed ID: 1382122
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide inhibitors attenuate N-methyl-D-aspartate excitotoxicity in rat hippocampal slices.
Izumi Y; Benz AM; Clifford DB; Zorumski CF
Neurosci Lett; 1992 Feb; 135(2):227-30. PubMed ID: 1625799
[TBL] [Abstract][Full Text] [Related]
30. Effect of nitric oxide synthase inhibition on long-term potentiation at associational-commissural and mossy fibre synapses on CA3 pyramidal neurones.
Nicolarakis PJ; Lin YQ; Bennett MR
Br J Pharmacol; 1994 Feb; 111(2):521-4. PubMed ID: 7516256
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of associative long-term depression by activation of beta-adrenergic receptors in rat hippocampal CA1 synapses.
Lin YW; Yang HW; Min MY; Chiu TH
J Biomed Sci; 2008 Jan; 15(1):123-31. PubMed ID: 17721829
[TBL] [Abstract][Full Text] [Related]
32. Nitric oxide synthase inhibitors block long-term potentiation induced by weak but not strong tetanic stimulation at physiological brain temperatures in rat hippocampal slices.
Haley JE; Malen PL; Chapman PF
Neurosci Lett; 1993 Sep; 160(1):85-8. PubMed ID: 7504222
[TBL] [Abstract][Full Text] [Related]
33. Adenosine acting on A1 receptors protects NO-triggered rebound potentiation and LTP in rat hippocampal slices.
Bon CL; Garthwaite J
J Neurophysiol; 2002 Apr; 87(4):1781-9. PubMed ID: 11929899
[TBL] [Abstract][Full Text] [Related]
34. Possible involvement of nitric oxide in long-term potentiation.
Böhme GA; Bon C; Stutzmann JM; Doble A; Blanchard JC
Eur J Pharmacol; 1991 Jul; 199(3):379-81. PubMed ID: 1915585
[TBL] [Abstract][Full Text] [Related]
35. Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum.
Shibuki K; Okada D
Nature; 1991 Jan; 349(6307):326-8. PubMed ID: 1702879
[TBL] [Abstract][Full Text] [Related]
36. Induction in the rat hippocampus of long-term potentiation (LTP) and long-term depression (LTD) in the presence of a nitric oxide synthase inhibitor.
Cummings JA; Nicola SM; Malenka RC
Neurosci Lett; 1994 Jul; 176(1):110-4. PubMed ID: 7526298
[TBL] [Abstract][Full Text] [Related]
37. Nitric oxide is required for the maintenance but not initiation of ganglionic long-term potentiation.
Altememi GF; Alkadhi KA
Neuroscience; 1999; 94(3):897-902. PubMed ID: 10579581
[TBL] [Abstract][Full Text] [Related]
38. An investigation of depotentiation of long-term potentiation in the CA1 region of the hippocampus.
Bashir ZI; Collingridge GL
Exp Brain Res; 1994; 100(3):437-43. PubMed ID: 7813681
[TBL] [Abstract][Full Text] [Related]
39. NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the L-arginine-nitric oxide pathway.
East SJ; Garthwaite J
Neurosci Lett; 1991 Feb; 123(1):17-9. PubMed ID: 1648186
[TBL] [Abstract][Full Text] [Related]
40. Hippocampal in vitro kindling is not blocked by nitric oxide synthase inhibitors.
Grooms SY; Jones LS
Neuroreport; 1994 May; 5(9):1102-4. PubMed ID: 7521682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
